SPARC Antibody, anti-human, FITC, REAdye_lease™, 200 µL
文献支持

SPARC Antibody, anti-human, FI

TC, REAdye_lease™, 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-129-890
  • 2025年12月09日
  • MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      SPARC

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REAL1146

    • 标记物

      FITC

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi biotec

    • 宿主

      cell line

    • 应用范围

      MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 抗体英文名

      SPARC Antibody, anti-human, REAdye_lease™

    • 抗体名

      SPARC Antibody, anti-human, REAdye_lease™

    • 规格

      200 µL

    Detection of SPARC+ cellsClone REAL1146 is an antibody fragment derived from the full SPARC antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL1146 recognizes SPARC, a 43kDa cysteine-rich acidic matrix-associated protein, which is also known as Osteonectin and ON. It is mainly detected in the extracellular compartment. SPARC has different functions. It plays a role in cell differentiation, proliferation and angiogenesis and is involved in tissue remodeling and wound repair. Expression of SPARC is detected in different tissues and organs and has been associated with tumor suppression. A strong expression is found in tissues undergoing morphogenesis and wound repair. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Feng, J. et al. (2014) SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target. Curr. Pharm. Des. 20 (39): 6182–6190. | Rosset, E. M. and Bradshaw, A. D. et al. (2016) SPARC/osteonectin in mineralized tissue. Matrix Biol. 52 (54): 78–87.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    询价
    艾美捷科技有限公司
    2025年07月13日询价
    ¥2299
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    询价
    武汉佰瑞得生物技术有限公司
    2025年07月13日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月10日询价
    文献支持
    SPARC Antibody, anti-human, FITC, REAdye_lease™, 200 µL
    询价